Jyske Bank
The share repurchase programme runs as from 28 January 2021 and up to and including 30 September 2021. In this period, Jyske Bank will acquire shares with a value of up to DKK 750 million, cf. Corporate Announcement No. 2/2021 of 28 January 2021. The share repurchase programme is initiated and structured in compliance with the EU Commission Regulation No. 596/2014 of 16 April 2014, the so-called "Market Abuse Regulation".
The following transactions have been made under the program:
| Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
| 28 January 2021 | 22,143 | 233.22 | 5,164,084 |
| 29 January 2021 | 22,745 | 231.41 | 5,263,339 |
| Accumulated under the programme | 44,888 | 232.30 | 10,427,423 |
With the transactions stated above, Jyske Bank now owns a total of 44,888 of treasury shares, excluding investments made on behalf of customers and shares held for trading purposes, corresponding to 0.06% of the share capital.
In accordance with the EU Commission Regulation No. 596/2014, transactions related to the share buy-back programme are attached to this corporate announcement in detailed form.
Yours faithfully,
Jyske Bank
Contact: Birger Krøgh Nielsen, CFO, tel. +45 89 89 64 44.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
The Magnum Ice Cream Company N.V.24.12.2025 11:52:30 CET | Press release
Director/PDMR Shareholding
Afarak Group SE24.12.2025 10:00:00 CET | Press release
AFARAK GROUP SE: DISTRIBUTION OF ASSETS FROM THE RESERVE FOR INVESTED UNRESTRICTED EQUITY
Sanofi Winthrop Industrie24.12.2025 07:15:00 CET | Press release
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
FLSmidth A/S24.12.2025 07:00:00 CET | Press release
FLSmidth: Transactions under share buy-back programme
Sanofi Winthrop Industrie24.12.2025 07:00:00 CET | Press release
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
